United Nations, D.o.E.a.S.A., Population Division, World Population Ageing 2015. 2015: (ST/ESA/SER.A/390).
Westendorp RG. What is healthy aging in the 21st century? Am J Clin Nutr. 2006;83(2):404S–9S.
CAS
PubMed
Google Scholar
Prince M, et al. World Alzheimer Report 2014: dementia and risk reduction: an analysis of protective and modifiable factors. London: Alzheimer’s Disease International (ADI); 2014.
Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med. 2007;9(3):1–17.
Article
PubMed
Google Scholar
Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000;31(2):578–85.
Article
CAS
PubMed
Google Scholar
Engelhart ST, et al. Prospective surveillance for healthcare-associated infections in German nursing home residents. J Hosp Infect. 2005;60(1):46–50.
Article
CAS
PubMed
Google Scholar
Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6):630–6.
Article
PubMed
Google Scholar
Katan M, et al. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology. 2013;80(13):1209–15.
Article
PubMed
PubMed Central
Google Scholar
Hodgson NA, et al. Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia. Alzheimer Dis Assoc Disord. 2011;25(2):109–15.
Article
PubMed
PubMed Central
Google Scholar
Crossley KB, Peterson PK. Infections in the elderly. Clin Infect Dis. 1996;22(2):209–15.
Article
CAS
PubMed
Google Scholar
McCloskey RM. Caring for patients with dementia in an acute care environment. Geriatr Nurs. 2004;25(3):139–44.
Article
PubMed
Google Scholar
Linhares I, et al. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC Infect Dis. 2013;13:19.
Article
PubMed
PubMed Central
Google Scholar
Davis DH, et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135(Pt 9):2809–16.
Article
PubMed
PubMed Central
Google Scholar
Fong TG, et al. Delirium accelerates cognitive decline in Alzheimer disease. Neurology. 2009;72(18):1570–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tilvis RS, et al. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59(3):268–74.
Article
PubMed
Google Scholar
Strandberg TE, et al. Cognitive impairment and infectious burden in the elderly. Arch Gerontol Geriatr Suppl. 2004;9:419–23.
Article
Google Scholar
Natalwala A, et al. Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002–2007. Dement Geriatr Cogn Disord. 2008;26(6):499–505.
Article
PubMed
Google Scholar
Dunn N, et al. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord. 2005;19(2):91–4.
Article
PubMed
Google Scholar
Holmes C, et al. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2003;74(6):788–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Holmes C, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73(10):768–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Foley NC, Affoo RH, Martin RE. A systematic review and meta-analysis examining pneumonia-associated mortality in dementia. Dement Geriatr Cogn Disord. 2015;39(1–2):52–67.
Article
PubMed
Google Scholar
Magaki S, et al. Comorbidity in dementia: update of an ongoing autopsy study. J Am Geriatr Soc. 2014;62(9):1722–8.
Article
PubMed
PubMed Central
Google Scholar
Tyas SL, et al. Risk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba,Canada. Int J Epidemiol. 2001;30(3):590–7.
Article
CAS
PubMed
Google Scholar
Verreault R, et al. Past exposure to vaccines and subsequent risk of Alzheimer’s disease. CMAJ. 2001;165(11):1495–8.
CAS
PubMed
PubMed Central
Google Scholar
Loeb MB, et al. A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease. J Am Geriatr Soc. 2004;52(3):381–7.
Article
PubMed
Google Scholar
Itzhaki RF, et al. Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging. 2004;25(5):619–27.
Article
CAS
PubMed
Google Scholar
Pisa D, et al. Different brain regions are infected with fungi in alzheimer’s disease. Scientific Reports, Published online: 15 October 2015. doi:10.1038/srep15015.
Honjo K, van Reekum R, Verhoeff NP. Alzheimer’s disease and infection: do infectious agents contribute to progression of Alzheimer’s disease? Alzheimers Dement. 2009;5(4):348–60.
Article
PubMed
Google Scholar
Jamieson GA, et al. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol. 1992;167(4):365–8.
Article
CAS
PubMed
Google Scholar
Itzhaki RF, et al. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997;349(9047):241–4.
Article
CAS
PubMed
Google Scholar
Piacentini R, et al. HSV-1 promotes Ca2 + -mediated APP phosphorylation and Abeta accumulation in rat cortical neurons. Neurobiol Aging. 2011;32(12):2323.e13-26.
Burgos JS, et al. Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J Virol. 2006;80(11):5383–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barnes LL, et al. Cytomegalovirus infection and risk of alzheimer disease in older black and white individuals. J Infect Dis. 2015;211(2):230–37.
Bu XL, et al. A study on the association between infectious burden and Alzheimer’s disease. Eur J Neurol. 2015;22(12):1519–25.
Carbone I, et al. Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol Aging. 2014;35(1):122–9.
Article
PubMed
Google Scholar
Westman G, et al. Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer’s disease. PLoS One. 2014;9(5):e96779.
Article
PubMed
PubMed Central
Google Scholar
Balin BJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol. 1998;187(1):23–42.
Article
CAS
PubMed
Google Scholar
Gérard HC, et al. The load of Chlamydia pneumoniae in the Alzheimer’s brain varies with APOE genotype. Microb Pathog. 2005;39(1-2):19–26.
Article
PubMed
Google Scholar
Gérard HC, et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol Med Microbiol. 2006;48(3):355–66.
Article
PubMed
Google Scholar
Maheshwari P, Eslick GD. Bacterial infection and Alzheimer’s disease: a meta-analysis. J Alzheimers Dis. 2015;43(3):957–66.
Harris SA, Harris EA. Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer’s disease. J Alzheimers Dis. 2015;48(2):319–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Appelt DM, et al. Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae. BMC Neurosci. 2008;9:13.
Article
PubMed
PubMed Central
Google Scholar
Little CS, et al. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging. 2004;25(4):419–29.
Article
CAS
PubMed
Google Scholar
Little CS, et al. Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front Aging Neurosci. 2014;6:304.
Article
PubMed
PubMed Central
Google Scholar
Shindler-Itskovitch T, et al. A systematic review and meta-analysis of the association between Helicobacter pylori infection and dementia. J Alzheimers Dis. 2016;52(4):1431–42.
Article
PubMed
Google Scholar
Beydoun MA, et al. Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosom Med. 2013;75(5):486–96.
Article
PubMed
PubMed Central
Google Scholar
Kountouras J, et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer’s disease. Int J Neurosci. 2009;119(6):765–77.
Article
CAS
PubMed
Google Scholar
Kountouras J, et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66(6):938–40.
Article
CAS
PubMed
Google Scholar
Roubaud-Baudron C, et al. Impact of chronic Helicobacter pylori infection on Alzheimer’s disease: preliminary results. Neurobiol Aging. 2012;33(5):1009.e11–9.
Article
PubMed
Google Scholar
Roubaud Baudron C, et al. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agées QUID Study. J Am Geriatr Soc. 2013;61(1):74–8.
Article
PubMed
Google Scholar
Kountouras J, et al. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol. 2010;23(3):199–204.
Article
PubMed
Google Scholar
Kountouras J, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. J Neurol. 2009;256(5):758–67.
Article
PubMed
Google Scholar
Wang XL, et al. Helicobacter pylori filtrate impairs spatial learning and memory in rats and increases β-amyloid by enhancing expression of presenilin-2. Front Aging Neurosci. 2014;6:66.
PubMed
PubMed Central
Google Scholar
Wang XL, et al. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3beta. J Alzheimers Dis. 2015;43(1):153–65.
PubMed
Google Scholar
Roubaud-Baudron C, et al. An eighteen-month helicobacter infection does not induce amyloid plaques or neuroinflammation in brains of wild type C57BL/6J mice. J Alzheimers Dis. 2015;45(4):1045–50.
CAS
Google Scholar
Kamer AR, et al. Periodontal disease associates with higher brain amyloid load in normal elderly. Neurobiol Aging. 2015;36(2):627–33.
Article
CAS
PubMed
Google Scholar
Cestari JA, et al. Oral infections and cytokine levels in patients with Alzheimer’s Disease and mild cognitive impairment compared with controls. J Alzheimers Dis. 2016;52(4):1479–85.
Article
CAS
PubMed
Google Scholar
Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease. Oral Microbiol Immunol. 2002;17(2):113–8.
Article
CAS
PubMed
Google Scholar
Poole S, et al. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis. 2013;36(4):665–77.
CAS
PubMed
Google Scholar
Miklossy J. Alzheimer’s disease—a spirochetosis? Neuroreport. 1993;4(7):841–8.
Article
CAS
PubMed
Google Scholar
Miklossy J, et al. Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis. 2004;6(6):639–49. discussion 673–81.
PubMed
Google Scholar
Miklossy J, et al. Beta-amyloid deposition and Alzheimer’s type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006;27(2):228–36.
Article
CAS
PubMed
Google Scholar
Miklossy J. Bacterial amyloid and DNA are important constituents of senile plaques: further evidence of the spirochetal and biofilm nature of senile plaques. J Alzheimers Dis. 2016;53(4):1459–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alonso R, et al. Fungal infection in patients with Alzheimer’s disease. J Alzheimers Dis. 2014;41(1):301–11.
CAS
PubMed
Google Scholar
Alonso R, et al. Cerebrospinal fluid from Alzheimer’s disease patients contains fungal proteins and DNA. J Alzheimers Dis. 2015;47(4):873–6.
Article
CAS
PubMed
Google Scholar
Alonso R, et al. Alzheimer’s disease and disseminated mycoses. Eur J Clin Microbiol Infect Dis. 2014;33(7):1125–32.
Article
CAS
PubMed
Google Scholar
Pisa D, et al. Direct visualization of fungal infection in brains from patients with Alzheimer’s disease. J Alzheimers Dis. 2015;43(2):613–24.
CAS
PubMed
Google Scholar
Soscia SJ, et al. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010;5(3):e9505.
Article
PubMed
PubMed Central
Google Scholar
Kumar DKV, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. 2016.
Google Scholar
Bourgade K, et al. Protective effect of amyloid-beta peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis. 2016;50(4):1227–41.
Article
CAS
PubMed
Google Scholar
Naylor K, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174(11):7446–52.
Article
CAS
PubMed
Google Scholar
Pawelec G, et al. T cells and aging, January 2002 update. Front Biosci. 2002;7:d1056–183.
Article
CAS
PubMed
Google Scholar
Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev. 1997;160:91–102.
Article
CAS
PubMed
Google Scholar
Haynes L, Swain SL. Why aging T cells fail: implications for vaccination. Immunity. 2006;24(6):663–6.
Article
CAS
PubMed
Google Scholar
Saresella M, et al. Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer’s disease. Brain Behav Immun. 2011;25(3):539–47.
Article
CAS
PubMed
Google Scholar
Larbi A, et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer’s disease. J Alzheimers Dis. 2009;17(1):91–103.
CAS
PubMed
Google Scholar
Schindowski K, et al. Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer’s disease-patients and T-cell hyporeactivity in an Alzheimer’s disease-mouse model: implications for immunotherapy. Neuromolecular Med. 2007;9(4):340–54.
Article
CAS
PubMed
Google Scholar
Panossian LA, et al. Telomere shortening in T cells correlates with Alzheimer’s disease status. Neurobiol Aging. 2003;24(1):77–84.
Article
CAS
PubMed
Google Scholar
Monsonego A, et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest. 2003;112(3):415–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saresella M, et al. PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2010;21(3):927–38.
CAS
PubMed
Google Scholar
Fiala M, et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2005;7(3):221–32. discussion 255-62.
CAS
PubMed
Google Scholar
Baglio F, et al. Neuroinflammation and brain functional disconnection in Alzheimer’s disease. Front Aging Neurosci. 2013;5:81.
Article
PubMed
PubMed Central
Google Scholar
Lueg G, et al. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer’s disease. Neurobiol Aging. 2015;36(1):81–9.
Article
CAS
PubMed
Google Scholar
Monson NL, et al. Elevated CNS inflammation in patients with preclinical Alzheimer’s disease. J Cereb Blood Flow Metab. 2014;34(1):30–3.
Article
CAS
PubMed
Google Scholar
McGeer PL, et al. Immune system response in Alzheimer’s disease. Can J Neurol Sci. 1989;16(4 Suppl):516–27.
Article
CAS
PubMed
Google Scholar
Togo T, et al. Occurrence of T cells in the brain of Alzheimer’s disease and other neurological diseases. J Neuroimmunol. 2002;124(1-2):83–92.
Article
CAS
PubMed
Google Scholar
McGeer PL, et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett. 1987;79(1–2):195–200.
Article
CAS
PubMed
Google Scholar
Togo T, et al. Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases. Brain Res. 2000;885(1):117–21.
Article
CAS
PubMed
Google Scholar
Browne TC, et al. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer’s disease. J Immunol. 2013;190(5):2241–51.
Article
CAS
PubMed
Google Scholar
McManus RM, et al. Respiratory infection promotes T cell infiltration and amyloid-beta deposition in APP/PS1 mice. Neurobiol Aging. 2014;35(1):109–21.
Article
CAS
PubMed
Google Scholar
Downer EJ, et al. Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory. PLoS One. 2013;8(5):e63194.
Article
CAS
PubMed
PubMed Central
Google Scholar
Della Bella S, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol. 2007;122(2):220–8.
Article
CAS
PubMed
Google Scholar
Ciaramella A, et al. Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptoms. J Neuroinflammation. 2016;13:18.
Article
PubMed
PubMed Central
Google Scholar
Ciaramella A, et al. Increased pro-inflammatory response by dendritic cells from patients with Alzheimer’s disease. J Alzheimers Dis. 2010;19(2):559–72.
PubMed
Google Scholar
Zhang R, et al. Systemic immune system alterations in early stages of Alzheimer’s disease. J Neuroimmunol. 2013;256(1-2):38–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saresella M, et al. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease. Mol Neurodegener. 2016;11:23.
Article
PubMed
PubMed Central
Google Scholar
Heneka MT, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493(7434):674–8.
Article
CAS
PubMed
Google Scholar
Barrett JP, et al. Bone marrow-derived macrophages from AbetaPP/PS1 mice are sensitized to the effects of inflammatory stimuli. J Alzheimers Dis. 2015;44(3):949–62.
CAS
PubMed
Google Scholar
Fiala M, et al. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood-brain barrier. Eur J Clin Invest. 2002;32(5):360–71.
Article
CAS
PubMed
Google Scholar
McManus RM, Mills KH, Lynch MA. T cells—protective or pathogenic in Alzheimer’s disease? J Neuroimmune Pharmacol. 2015;10(4):547–60.
Article
PubMed
Google Scholar